Dear valued user,
Thank you for using Clearpol. Your support has been invaluable to us and we truly appreciate it. We launched Clearpol two years ago and thousands of users like you have joined us in our mission to simplify healthcare compliance. During the pandemic, we put Clearpol out for free as our way of helping, so you could focus on taking care of your residents.
Listen to our origin story here
As we move forward, we are determined to empower you with cutting-edge AI-enabled tools that will make managing compliance effortless. To bring this vision to life we've partnered with UC Berkeley, a leader in public health and AI research. We will also launch a PRO subscription starting March 1st to ensure the sustainability of Clearpol and to continuously improve the platform for all users. After March 1st, many existing, new, and future features will require a PRO subscription.
As a token of appreciation, we will be offering early adopters, students, and other special users the opportunity to be grandfathered in at an incredibly steep discount. Look out for future communications if you fall into that category.
Thank you for your understanding and continued support. We look forward to serving you in the future.
Best regards,
The Clearpol Team
The Comparison for this document will be available soon.
Your account is being upgraded to Pro!
Signup for Clearpol Pro to benefit from the following premium features and more...
$55/month
$45/month
Try Free for 2 Weeks$350/month
$250/month
Try Free for 2 WeeksWe're sorry to hear that! Help us improve our service, please take a moment to tell us why.
Signup for Clearpol Pro to benefit from the following premium features and more...
$55/month
$45/month
Try Free for 2 Weeks$350/month
$250/month
Try Free for 2 WeeksWe're sorry to hear that! Help us improve our service, please take a moment to tell us why.
Signup for Clearpol Pro to benefit from the following premium features and more...
$55/month
$45/month
Try Free for 2 Weeks$350/month
$250/month
Try Free for 2 WeeksWe're sorry to hear that! Help us improve our service, please take a moment to tell us why.
Signup for Clearpol Pro to benefit from the following premium features and more...
$55/month
$45/month
Try Free for 2 Weeks$350/month
$250/month
Try Free for 2 WeeksWe're sorry to hear that! Help us improve our service, please take a moment to tell us why.
The information provided is used to show regulations that are relevant to your region/facility. By using the platform you agree to the terms and conditions.
COVID-19 Vaccine Recommendations to clinically eligible individuals. Supersedes AFL 22-09.1. Includes information related to updated COVID-19 vaccines.
COVID-19 vaccination is recommended for everyone ages 6 months and older in the United States for the prevention of COVID-19. There is no preferential recommendation for the use of any one COVID-19 vaccine over another when more than one recommended and age-appropriate vaccine is available. The 2023–2024 formulation for all COVID-19 vaccines licensed or authorized in the United States (Moderna, Novavax, and Pfizer-BioNTech) has been updated to a monovalent vaccine based on the Omicron XBB.1.5 sublineage of SARS-CoV-2. The original monovalent and bivalent (Original and Omicron BA.4/BA.5) formulations should no longer be used.
Everyone should stay up to date with COVID-19 vaccines:
· Everyone 5 years of age and older is recommended to receive a single updated dose as long as it has been at least 2 months since their last dose. For assistance in obtaining COVID-19 vaccinations, MyTurn or CDC Vaccines. Vaccines available from COVID-19 vaccine manufacturers or wholesale distributors. Providers serving uninsured patients can inquire about participation in the Bridge Access Program.
Clearpol Inc. does not make any guarantees regarding the accuracy of the opinions provided on our platform. Please use your own judgement.
Clearpol Inc. does not make any guarantees regarding the accuracy of the opinions or summaries provided on our platform. Please use your own judgement.
| Task | Deadline | Actions |
|---|
Click below to print the document in a new window. When finished, you can return to this tab to continue.
Print PDF
Copy Document Link
Please enter a Name.
Please enter a valid email address.
Please enter a first name.
Please enter a last name.
Please enter a valid email address.
